Blueberries Medical Corp.
BBRRF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.14 | 0.11 | -0.02 | -0.02 |
| FCF Yield | -1.24% | -1.60% | -15.91% | -4.05% |
| EV / EBITDA | -45.91 | -37.09 | -6.77 | -15.67 |
| Quality | ||||
| ROIC | -22.14% | -20.39% | -64.74% | -21.97% |
| Gross Margin | 69.26% | 44.04% | 39.30% | 30.50% |
| Cash Conversion Ratio | 0.50 | 0.53 | 1.08 | 0.60 |
| Growth | ||||
| Revenue 3-Year CAGR | 13.16% | 12.68% | 16.11% | 26.04% |
| Free Cash Flow Growth | 13.25% | 87.15% | -265.18% | -12.53% |
| Safety | ||||
| Net Debt / EBITDA | 0.08 | 0.79 | 0.39 | 0.15 |
| Interest Coverage | 0.00 | -2,688.03 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.05 | 0.14 | 0.14 | 0.75 |
| Cash Conversion Cycle | 34.25 | -77.03 | -190.70 | 21.66 |